These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22567063)

  • 21. The place of the crossover design in infertility trials: a maximum likelihood approach.
    McDonnell J; Goverde AJ; Vermeiden JP
    Hum Reprod; 2004 Nov; 19(11):2537-44. PubMed ID: 15459169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjusting pairwise nonparametric equivalence hypothesis tests and confidence intervals for period effects in 3 x 3 crossover trials.
    Duchateau L; Janssen P; Straetemans R; Otoul C
    J Biopharm Stat; 2002 May; 12(2):149-60. PubMed ID: 12413237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crossover studies with continuous variables: power analysis.
    Cleophas TJ; Zwinderman AH
    Am J Ther; 2002; 9(1):69-73. PubMed ID: 11782821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The two-period crossover design in medical research.
    Woods JR; Williams JG; Tavel M
    Ann Intern Med; 1989 Apr; 110(7):560-6. PubMed ID: 2923388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-period crossover trials.
    Matthews JN
    Stat Methods Med Res; 1994 Dec; 3(4):383-405. PubMed ID: 7889228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs.
    Yan Z
    Stat Med; 2013 Mar; 32(6):956-63. PubMed ID: 22903413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis combining parallel and crossover trials using generalised estimating equation method.
    Curtin F
    Res Synth Methods; 2017 Sep; 8(3):312-320. PubMed ID: 28585280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A note on misspecification in general linear models with correlated errors for the analysis of crossover clinical trials.
    Wang W; Cong N; Chen T; Zhang H; Zhang B
    PLoS One; 2019; 14(3):e0213436. PubMed ID: 30870443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of alternative statistical models for crossover studies to demonstrate caffeine adjuvancy in the treatment of tension headache.
    Koch GG; Amara IA; MacMillan J
    J Biopharm Stat; 1994 Nov; 4(3):347-410. PubMed ID: 7881452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of a crossover clinical trial by permutation methods.
    Good P; Xie F
    Contemp Clin Trials; 2008 Jul; 29(4):565-8. PubMed ID: 18356118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A recommended analysis for 2 × 2 crossover trials with baseline measurements.
    Mehrotra DV
    Pharm Stat; 2014; 13(6):376-87. PubMed ID: 25230245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).
    Brettschneider C; Lühmann D; Raspe H
    GMS Health Technol Assess; 2011 Feb; 7():Doc01. PubMed ID: 21468289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-period crossover designs for two treatments.
    Ebbutt AF
    Biometrics; 1984 Mar; 40(1):219-24. PubMed ID: 6733230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The crossover experiment for clinical trials.
    Brown BW
    Biometrics; 1980 Mar; 36(1):69-79. PubMed ID: 7370374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crossover and self-controlled designs in clinical research.
    Louis TA; Lavori PW; Bailar JC; Polansky M
    N Engl J Med; 1984 Jan; 310(1):24-31. PubMed ID: 6689736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An alternative analysis for crossover studies that accounts for between-group disparities in drug response.
    Cleophas TJ
    Eur J Clin Chem Clin Biochem; 1997 Oct; 35(10):775-9. PubMed ID: 9368796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crossover design and its application in late-phase diabetes studies.
    Wang T; Malone J; Fu H; Heilmann C; Qu Y; Huster WJ
    J Diabetes; 2016 Sep; 8(5):610-8. PubMed ID: 27100270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underestimation of treatment effect in crossover trials.
    Cleophas TJ
    Angiology; 1990 Sep; 41(9 Pt 1):673-80. PubMed ID: 2221469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivariate nonparametric analysis for the two-period crossover design with application in clinical trials.
    Johnson WD; Grender JM
    J Biopharm Stat; 1993 Mar; 3(1):1-12. PubMed ID: 8485530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.